pirinixic acid has been researched along with Chronic Disease in 1 studies
pirinixic acid: structure
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
Excerpt | Relevance | Reference |
---|---|---|
"Pulmonary hypertension is a fatal disease; however, its pathogenesis still remains to be elucidated." | 1.46 | Activated TAFI Promotes the Development of Chronic Thromboembolic Pulmonary Hypertension: A Possible Novel Therapeutic Target. ( Al-Mamun, E; Kikuchi, N; Kurosawa, R; Miyata, S; Morser, J; Nogi, M; Numano, K; Omura, J; Satoh, K; Satoh, T; Shimokawa, H; Siddique, MA; Sunamura, S; Suzuki, K; Yaoita, N, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Satoh, T | 1 |
Satoh, K | 1 |
Yaoita, N | 1 |
Kikuchi, N | 1 |
Omura, J | 1 |
Kurosawa, R | 1 |
Numano, K | 1 |
Al-Mamun, E | 1 |
Siddique, MA | 1 |
Sunamura, S | 1 |
Nogi, M | 1 |
Suzuki, K | 1 |
Miyata, S | 1 |
Morser, J | 1 |
Shimokawa, H | 1 |
1 other study available for pirinixic acid and Chronic Disease
Article | Year |
---|---|
Activated TAFI Promotes the Development of Chronic Thromboembolic Pulmonary Hypertension: A Possible Novel Therapeutic Target.
Topics: Adult; Animals; Arterial Pressure; Capillary Permeability; Carboxypeptidase B2; Case-Control Studies | 2017 |